Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
Minimizing the risk of relapse is essential in multiple sclerosis (MS). As none of the treatments currently available are capable of completely preventing relapses, treatment of these episodes remains a cornerstone of MS care. The objective of this manuscript is to reduce uncertainty and improve qua...
Main Authors: | Cristina Ramo-Tello, Yolanda Blanco, Luis Brieva, Bonaventura Casanova, Eva Martínez-Cáceres, Daniel Ontaneda, Lluís Ramió-Torrentá, Àlex Rovira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/1/6 |
Similar Items
-
Definition and treatment of the multiple sclerosis relapse (ORP-10)
by: Maryam Poursadeghfard
Published: (2023-11-01) -
Outcome of MS relapses in the era of disease-modifying therapy
by: Muriel Stoppe, et al.
Published: (2017-08-01) -
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
by: Steffen Pfeuffer, et al.
Published: (2022-09-01) -
Satisfaction, Safety and Cost of the Treatment for Multiple Sclerosis Relapse with Intravenous versus Oral Methylprednisolone
by: Montserrat Gonzalez-Platas, et al.
Published: (2018-10-01) -
Management of acute exacerbations in multiple sclerosis
by: Ontaneda Daniel, et al.
Published: (2009-01-01)